Clinical validation

Workpackage #6

Clinical validation

The primary objective of WP6 is to validate the models produced in WP5 by analysing the development, risk and progression of CVD, and Heart Failure.  
 
WP6 will aim to validate the most promising treatment response prediction model in a Phase 2B trial in the hopes of validating interaction between biomarker profile and treatment response determined in earlier WPs.

This means that treatment will be individually adjusted based on the biomarker profile and compared to a control group (who will receive standard care). Patients will be randomly allocated to one of these groups for 15 months, where the main outcome we will look for will be whether the biomarker guided treatment response leads to an improvement in CVD condition compared to standard care.  
 
Lastly, WP6 will also focus on continuing the prospective trial in type1 diabetes from WP1 but will enhance the intervention by validating the model produced in WP5 to predict patients most likely to benefit from cardio-renal protection therapy. 

Meet our team

University Medical Center Groningen

Adriaan Voors , Professor

Department of Cardiology

Decentriq

Maria Fernanda Scoz Luz

Business Development Manager

Decentriq

Nikolas Molyndris

Product Lead, Healthcare & Life science

Human Technopole

Emanuele Di Angelantonio

Head of Health Data Science Centre

Human Technopole

Giulia Mangiameli

Scientific Project Manager

Queen’s University Belfast

Loreena Hill , Dr.

Queen ’ s University, Belfast

Queen’s University Belfast

Donna Fitzsimons

Professor of Nursing & Head of School of Nursing & Midwifery

Lilly

Flora Sam, Dr.

Vice President, Heart Failure and Kidney Early Phase Cardiovascular Research & Clinical Research – Diabetes, Obesity & Complications

IMEC

John Morales

Researcher
Get updated

Our related news

30 January, 2025

First Patient Advisory Board meeting

Today marked a significant milestone for the iCARE4CVD project, as the newly..

28 January, 2025

Launch of Patient Panels – First meeting in Dublin

In iCARE4CVD, Patient Panels are groups of individuals living with CVD who..

10 September, 2024

New publication: Evaluating digital care for heart failure using patient experience measures – A scoping review

Heart failure (heart failure) is a serious condition that affects many people..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.